• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL1500036 噻托溴铵喷雾剂 tiotropium bromide Spray Chemical Drugs Import Drug Application 2015-02-13 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH Certificate Issued 2016-09-05 view
JYHB2001596 吸入用异丙托溴铵溶液 ipratropium bromide Inhalation Chemical Drugs Supplementary Application 2020-08-28 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Laboratoire Unither;Boehringer Ingelheim Pharma Gmbh & Co KG Filed 2020-09-09 view
JYHB1700983 尼达尼布软胶囊 nintedanib Soft capsules Chemical Drugs Supplementary Application 2017-07-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH Certificate Issued 2017-12-17 view
JYHB1800303 替米沙坦氢氯噻嗪片 hydrochlorothiazide;telmisartan Tablet Chemical Drugs Supplementary Application 2018-03-12 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ellas Ae Certificate Issued 2019-07-31 view
JYHB1901348 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2019-11-06 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH Filed 2019-11-21 view
JXHL2000125 BI 1701963 片 BI 1701963 Tablet Chemical Drugs(1) Import Drug Application 2020-06-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2020-06-04 view
JYHB2000895 达比加群酯胶囊 dabigatran etexilate Capsule Chemical Drugs Supplementary Application 2020-06-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG Filed 2020-06-22 view
JYHB1600656 吸入用异丙托溴铵溶液 ipratropium bromide Inhalation Chemical Drugs Supplementary Application 2016-06-02 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Laboratoire Unither;Boehringer Ingelheim Pharma Gmbh & Co KG Certificate Issued 2017-03-13 view
JYHF1700118 利格列汀片 linagliptin Tablet Chemical Drugs Supplementary Application 2017-11-27 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;West-Ward Columbus Inc Certificate Issued 2018-01-04 view
JYHB1801429 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2018-12-17 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH Certificate Issued 2019-02-26 view
JYHB2000373 盐酸普拉克索片 pramipexole dihydrochloride Tablet Chemical Drugs Supplementary Application 2020-04-10 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG Certificate Issued 2021-07-28 view
JYHB1502476 吸入用异丙托溴铵溶液 ipratropium bromide Inhalation Chemical Drugs Supplementary Application 2015-12-17 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Laboratoire Unither;Boehringer Ingelheim Pharma Gmbh & Co KG Certificate Issued 2016-11-15 view
JXHL2100019 BI685509片 avenciguat Tablet Chemical Drugs(1) Import Drug Application 2021-01-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2021-01-18 view
JYHB1800933 尼达尼布软胶囊 nintedanib Soft capsules Chemical Drugs Supplementary Application 2018-08-15 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH Certificate Issued 2018-10-22 view
JYHB2000037 马来酸阿法替尼片 Afatinib Dimaleate Tablet Chemical Drugs Supplementary Application 2020-01-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG Filed 2020-02-07 view
JXHL1500120 阿法替尼片 Afatinib Dimaleate Tablet Chemical Drugs Import Drug Application 2015-05-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH Certificate Issued 2016-03-25 view
JXHS2000168 恩格列净片 empagliflozin Tablet Chemical Drugs(2.4) Import Drug Application 2020-11-18 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG In Review 2020-11-18 view
JYHB1701276 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2017-10-09 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG Certificate Issued 2017-10-30 view
JYHB1800450 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2018-05-09 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG Certificate Issued 2018-07-10 view
JXHS1900155 利格列汀片 linagliptin Tablet Chemical Drugs(5.1) Import Drug Application 2019-12-09 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;West-Ward Columbus Inc Certificate Issued 2021-03-05 view